CAC Software vs ZEUS System
AI Verdict
Choose CAC Software if…
Choose Imbio's CAC Software if you need to assess a patient's risk for coronary artery disease by quantifying calcification in their coronary arteries. This tool is ideal for radiologists and cardiologists seeking automated, deep-learning based analysis of non-contrast chest CT scans to generate an Agatston score and provide 3D visualizations for comprehensive risk stratification.
View CAC Software →Choose ZEUS System if…
Choose iRhythm Technologies' ZEUS System if you require long-term continuous cardiac monitoring to detect and characterize arrhythmias, such as Atrial Fibrillation. This AI-powered solution is best suited for physicians in cardiology, family medicine, or internal medicine who need to analyze ECG data from wearable biosensors for up to 14 days to identify both symptomatic and asymptomatic cardiac events.
View ZEUS System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CAC Software | ZEUS System |
|---|---|---|
| Pricing | Unknown | Not disclosed |
| Deployment | Cloud-based (SaaS), integrates with PACS | Cloud-based (AWS EC2 platform), no on-premise hardware. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieBoth tools are designed for seamless integration into existing clinical workflows. Tool A integrates into standard DICOM viewing workflows for radiologists, providing 3D visualizations and annotated images. Tool B offers cloud-based analytics, preliminary report generation, and HL7-based EHR integration for physicians managing continuous ECG monitoring. Given their distinct target users and integration points, neither can be definitively declared superior in overall usability without user-specific feedback.
Clinical Value
TieBoth tools offer significant and distinct clinical value in their respective domains within cardiology. Tool A provides automated, quantitative assessment of coronary artery calcification for CAD risk assessment. Tool B enables AI-powered, long-term continuous ECG monitoring for early arrhythmia detection and characterization. Both are FDA cleared, validating their clinical utility and safety.
Pricing & Value
TieNeither Tool A nor Tool B discloses specific pricing information in the provided structured facts or readily available online. Both require direct contact for pricing details. Without transparent pricing, it is impossible to conduct a meaningful comparison of their cost-effectiveness or overall value proposition.
Enterprise Readiness
CAC SoftwareTool A offers greater deployment flexibility, supporting Cloud, On-premise, and Partner platforms. This range of options can be crucial for enterprises with varying IT infrastructure preferences and data governance requirements. While Tool B is also HIPAA compliant, has a BAA, and integrates with EHRs, its cloud-only deployment may be a limitation for some organizations.
Innovation
ZEUS SystemTool B demonstrates a more disruptive innovation by combining AI-powered analysis with wearable biosensors for long-term continuous cardiac monitoring. This approach extends diagnostic capabilities beyond traditional clinical settings, enabling early detection and management of arrhythmias. While Tool A's deep-learning based image analysis is innovative, Tool B's integration with wearables for continuous patient monitoring represents a more transformative step in patient care delivery.
Support & Docs
ZEUS SystemTool B provides more readily accessible and comprehensive support resources, including 24/7 patient support via phone and email, and downloadable Instructions for Use and Clinical Reference Manuals in multiple languages. Tool A offers online case submission, phone, and email support during business hours, with documentation available upon request. Tool B's transparent and multi-faceted approach to support and documentation gives it an edge.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CAC Software | ZEUS System |
|---|---|---|
| Name | CAC Software | ZEUS System |
| Company | Imbio | iRhythm Technologies |
| Description | Automated image post-processing algorithms designed to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries in patients who have undergone a non-contrast, chest computed tomography (CT). | AI-powered software that analyzes ECG data from wearable biosensors for long-term continuous cardiac monitoring, aiding in the detection and characterization of arrhythmias like Atrial Fibrillation. |
| Primary Function | Coronary Artery Calcification (CAC) quantification | Arrhythmia detection and characterization from ECG data |
| Data Input | Non-contrast chest computed tomography (CT) scans | ECG data from wearable biosensors |
| Key Output/Analysis | Agatston score, arterial age, calcified lesion mass and volume, 3D visualizations, annotated images | Detection and characterization of Atrial Fibrillation (AFib), preliminary report generation |
Videos
Demos, reviews, and walkthroughs featuring CAC Software and ZEUS System.
Frequently Asked Questions
More Comparisons
More matchups featuring CAC Software or ZEUS System
Backers
Who funded each tool's parent company.